Related Experiment Video
Updated: May 27, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Projected and observed diabetes epidemics in China and beyond
1Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, No. 2 Anzhen Street, Chaoyang District, Beijing 100029, China. deezhao@vip.sina.com
Current Cardiology Reports
|November 8, 2011
Summary
Global diabetes prevalence is underestimated by projections. China
Area of Science:
- Endocrinology
- Public Health
- Epidemiology
Background:
- Diabetes mellitus is a significant global noncommunicable disease.
- Accurate projections of diabetes prevalence are crucial for public health planning.
- International literature shows varying reported trends in diabetes incidence and prevalence.
Purpose of the Study:
- To compare projected and observed trends of diabetes prevalence and incidence globally.
- To analyze the accuracy of diabetes epidemic projections, particularly in China.
- To identify potential underestimation in future diabetes burden predictions.
Main Methods:
- Systematic review of international literature on diabetes prevalence and projections.
- Comparative analysis of projected versus observed diabetes data for China (2000-2030).
- Inclusion of data from national surveys and international research.
Main Results:
- Projected diabetes burden in China consistently underestimated actual prevalence and numbers.
- Observed 2008 diabetes figures in China (9.7% prevalence, 92.4 million people) far exceeded projections for 2009-2010 and even 2030.
- Underestimation of diabetes epidemics is a global trend, particularly in low- and middle-income countries.
Conclusions:
- Existing diabetes projections significantly underestimate the epidemic's scale, especially in China.
- Future diabetes epidemic predictions require revision to account for higher-than-expected prevalence.
- Urgent public health strategies are needed to address the escalating global diabetes burden.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...